Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0331ATC

LN-229 Human Brain Glioblastoma Epithelial Cells

Tumor Cell Lines > Nerve Tumor Cell Lines

Product Type: Human Nerve Tumors Cell Lines

Species: Human

Cell Type: Epithelial Cells

Source Organ: Brain

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: LN-229

Tissue: Brain/right frontal parieto-occipital cortex.

  • Description
    LN-229 is a human glioblastoma cell line established in 1979 from a right frontal parieto-occipital glioblastoma tumor tissue of a 60-year-old European female patient. This epithelial-like cell line grows under adherent culture properties with a doubling time of approximately 31 hours. Karyotype analysis reveals a hyperdiploid chromosomal complement with notable chromosomal instability, including multiple copies of chromosomes 12 and 19. Molecular characterization identifies a TP53 mutation (CCT→CTT transition at codon 98) and homozygous deletions of tumor suppressors p16 and p14ARF, despite retaining wild-type PTEN. LN-229 demonstrates tumorigenicity in nude mouse models, forming subcutaneous tumors upon implantation. These genetic and functional characteristics make LN-229 a relevant preclinical model for glioblastoma biology and treatment resistance.
  • Product Name
    LN-229
  • Product Type
    Human Nerve Tumors Cell Lines
  • Species
    Human
  • Cell Type
    Epithelial
  • Source Organ
    Brain
  • Disease
    Glioblastoma
  • Product Type
    Human Nerve Tumors Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    LN-229 cells are a widely utilized model in glioblastoma research, particularly for investigating the molecular mechanism under tumor proliferation, genomic instability and therapeutic resistance. The presence of a mutant TP53, deletions in cell cycle regulators, and intact PTEN function provide a representative genetic background for studying key signaling pathways in gliomagenesis. Furthermore, LN-229 is frequently used in the development of advanced radiotherapy strategies. Its use in both basic neuroscience and translational oncology underscores its value in identifying and validating novel therapeutic targets and improving treatment modalities for high-grade gliomas.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    DMEM + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you